首页|逍遥散加减方对肝郁脾虚型失眠患者睡眠质量的影响

逍遥散加减方对肝郁脾虚型失眠患者睡眠质量的影响

扫码查看
目的 观察逍遥散加减方对肝郁脾虚型失眠患者睡眠质量的影响.方法 60 例中医辨证为肝郁脾虚型失眠患者,采用随机数字表法将患者分为对照组(30 例)和研究组(30 例).对照组给予阿普唑仑片治疗,研究组在对照组基础上加用逍遥散加减方治疗.比较两组患者临床疗效以及治疗前后的匹兹堡睡眠质量指数量表(PSQI)、失眠严重严重指数量表(ISI)评分.结果 研究组临床总有效率96.67%显著高于对照组的80.00%,差异具有统计学意义(P<0.05).治疗后,两组患者PSQI评分与ISI评分均有不同程度的降低,且研究组患者PSQI评分(6.12±0.66)分、ISI评分(6.90±0.71)分均低于对照组的(9.70±0.99)、(10.25±1.09)分,差异有统计学意义(P<0.05).结论 逍遥散加减方治疗肝郁脾虚型失眠的临床疗效确切.
Effect of modified Xiaoyao Powder on sleep quality of patients with insomnia of liver depression and spleen deficiency type
Objective To observe the effect of modified Xiaoyao Powder on sleep quality of patients with insomnia of liver depression and spleen deficiency type.Methods 60 patients with insomnia of liver depression and spleen deficiency type were selected as the research subjects.The patients were divided into a control group(30 cases)and a study group(30 cases)using a random number table method.The control group was treated with alprazolam tablets,while the study group was treated with modified Xiaoyao Powder on the basis of the control group.The clinical efficacy,Pittsburgh Sleep Quality Index(PSQI)scale and Insomnia Severity Index(ISI)score before and after treatment were compared between the two groups.Results The total clinical effective rate of the study group was 96.67%,which was significantly higher than 80.00%of the control group,and the difference was statistically significant(P<0.05).After treatment,PSQI scores and ISI scores in both groups reduced to varying degrees;the study group had PSQI score of(6.12±0.66)points and ISI score of(6.90±0.71)points,which were lower than(9.70±0.99)and(10.25±1.09)points in the control group;the difference was statistically significant(P<0.05).Conclusion The clinical efficacy of modified Xiaoyao Powder in treating insomnia of liver depression and spleen deficiency type is definite.

Xiaoyao PowderLiver depression and spleen deficiency typeInsomniaSleep qualityEfficacy

侣丽萍

展开 >

537100 贵港市人民医院

逍遥散 肝郁脾虚 失眠 睡眠质量 疗效

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(12)